Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term follow-up of cytogenetically normal CEBPA-mutated AML.

Journal of hematology & oncology - 10 Sept 2014

Pastore Friederike, Kling Daniela, Hoster Eva, Dufour Annika, Konstandin Nikola P, Schneider Stephanie, Sauerland Maria C, Berdel Wolfgang E, Buechner Thomas, Woermann Bernhard, Braess Jan, Hiddemann Wolfgang, Spiekermann Karsten

Abstract excerpt

BACKGROUND: The aim of this study was to analyze the long-term survival of AML patients with CEBPA mutations. PATIENTS AND METHODS: We investigated 88 AML patients with a median age of 61 years and (1) cytogenetically normal AML (CN-AML), (2) monoallelic (moCEBPA) or biallelic (biCEBPA) CEBPA mutation, and (3) intensive induction treatment. 60/88 patients have been described previously with a shorter follow-up....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CCAAT-Enhancer-Binding Proteins

Share to Disease-Free Survival

Share to Follow-Up Studies

Share to Kaplan-Meier Estimate

Share to Leukemia, Myeloid, Acute

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 25214041
DOI: 10.1186/s13045-014-0055-7
PMCID: PMC4172831

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term follow-up of cytogenetically normal CEBPA-mutated AML.PMID 25214041Read ↗

Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.Semantic proximity Read ↗

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.Semantic proximity Read ↗

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.Semantic proximity Read ↗

Novel insights of acute myeloid leukemia with CEBPA deregulation: Heterogeneity dissection and re-stratification.Semantic proximity Read ↗

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.Semantic proximity Read ↗

Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPASemantic proximity Read ↗

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.Semantic proximity Read ↗

Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical OutcomeSemantic proximity Read ↗

Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.Semantic proximity Read ↗

The clinical characteristics and prognosis of cytogenetically normal AML with single mutations of CEBPA.Semantic proximity Read ↗

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupSemantic proximity Read ↗

Clonal Evolution of Acute Myeloid Leukemia with CEBPA Double Mutations after Long-Term Remission: Case Report and a Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.